Christophe Baudouin
Overview
Explore the profile of Christophe Baudouin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
298
Citations
6697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amatu J, Amatu J, Bastelica P, Bastelica P, Baudouin C, Baudouin C
Am J Ophthalmol
. 2025 Mar;
PMID: 40024358
No abstract available.
2.
Baudouin C, Stalmans I, Bourne R, Larrosa J, Schmickler S, Seleznev A, et al.
Eye (Lond)
. 2025 Feb;
PMID: 40000909
Background/objectives: To evaluate the efficacy and safety of preservative-free latanoprost eye drop emulsion in reducing intraocular pressure (IOP) versus preserved latanoprost in open-angle glaucoma (OAG) or ocular hypertension (OHT). Methods:...
3.
Bastelica P, Magny R, Poupon J, Sonigo B, Aubert T, Brignole-Baudouin F, et al.
BMC Ophthalmol
. 2024 Dec;
24(1):535.
PMID: 39696055
Background: The EyeCee ONE intraocular lens (Nidek, Gamagori, Japan) has been withdrawn from the market due to a high number of reports of severe ocular hypertension (OHT) following phacoemulsification with...
4.
Liang H, Baudouin C, Giordano V
Br J Ophthalmol
. 2024 Oct;
PMID: 39357989
Aims: To analyse the correlation between the physician categories defined by the 3C classification (crystal-complication-compliance) and the ocular manifestations of nephropathic cystinosis. Methods: The last visit data of 64 patients...
5.
Reboussin E, Bastelica P, Benmessabih I, Cordovilla A, Delarasse C, Reaux-Le Goazigo A, et al.
Acta Neuropathol Commun
. 2024 Sep;
12(1):150.
PMID: 39300576
Background: Glaucoma is a leading cause of blindness, affecting retinal ganglion cells (RGCs) and their axons. By 2040, it is likely to affect 110 million people. Neuroinflammation, specifically through the...
6.
Bastelica P, Labbe A, Hamard P, Rossant F, Urien H, Sublime J, et al.
J Glaucoma
. 2024 Sep;
33(12):957-963.
PMID: 39254572
Prcis: The lamina cribrosa (LC) pores of patients with high-tension glaucoma (HTG) appear to take a more tortuous pathway than the LC pores of patients with non-glaucomatous (NG). Objective: To...
7.
Blautain B, Rabut G, Dupas B, Riancho L, Liang H, Luzu J, et al.
Transl Vis Sci Technol
. 2024 Aug;
13(8):39.
PMID: 39177993
Purpose: The purpose of this study was to determine the association between corneal images provided by in vivo confocal microscopy (IVCM) with clinical parameters and conjunctival expression of HLA-DR antigen...
8.
Kahook M, Rapuano C, Messmer E, Radcliffe N, Galor A, Baudouin C
Ocul Surf
. 2024 Aug;
34:213-224.
PMID: 39098762
Ocular surface disease (OSD) is a complex condition that can cause a range of symptoms (e.g, dryness, irritation, and pain) and can significantly impact the quality of life of affected...
9.
Bonneau N, Potey A, Blond F, Guerin C, Baudouin C, Peyrin J, et al.
Front Cell Neurosci
. 2024 Jul;
18:1417653.
PMID: 39076204
Introduction: Damage to the corneal nerves can result in discomfort and chronic pain, profoundly impacting the quality of life of patients. Development of novel method is crucial to better understand...
10.
Messmer E, Baudouin C, Benitez-Del-Castillo J, Iester M, Anton A, Thygesen J, et al.
J Glaucoma
. 2024 Jul;
33(10):715-727.
PMID: 39018018
Prcis: We have developed through a consensus process 24 clinical recommendations for the comprehensive management of ocular surface inflammation in glaucoma patients, including diagnostic criteria, prevention measures, and treatment strategies...